tiprankstipranks
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ

Jazz Pharmaceuticals (JAZZ) Financial Statements

1,418 Followers

Jazz Pharmaceuticals Financial Overview

Jazz Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $4.597; its P/E ratio is 23.16; Jazz Pharmaceuticals is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $4.80. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.01B$ 972.14M$ 946.99M$ 892.81M$ 972.12M
Gross Profit$ 904.69M$ 1.07B$ 1.05B$ 764.17M$ 804.76M
EBIT-$ 99.52M$ 81.78M$ 54.10M$ -265.87M
EBITDA-$ 262.08M$ 241.36M$ 211.46M$ -128.48M
Net Income Common Stockholders$ 94.15M$ 146.82M$ 104.44M$ 69.42M$ -240.72M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.51B$ 1.34B$ 1.28B$ 1.17B$ 881.48M
Total Assets$ 11.39B$ 11.20B$ 11.26B$ 11.04B$ 10.84B
Total Debt$ 5.77B$ 5.78B$ 5.78B$ 5.80B$ 5.81B
Net Debt$ 4.27B$ 4.44B$ 4.50B$ 4.63B$ 4.92B
Total Liabilities$ 7.66B$ 7.71B$ 7.73B$ 7.72B$ 7.76B
Stockholders Equity$ 3.74B$ 3.49B$ 3.53B$ 3.34B$ 3.09B
Cash Flow-
Free Cash Flow-$ 302.90M$ 291.03M$ 315.89M$ 332.59M
Operating Cash Flow$ 167.34M$ 307.19M$ 296.76M$ 319.71M$ 341.97M
Investing Cash Flow$ 101.80M$ -174.30M$ -85.74M$ -4.82M$ -324.38M
Financing Cash Flow$ -100.31M$ -78.49M$ -96.67M$ -28.79M$ 19.60M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

Jazz Pharmaceuticals Debt to Assets

Jazz Pharmaceuticals Cash Flow

Jazz Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis